2 active not recruiting, 2 completed. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 2, Completed 2 |
| Phase 2 | 4 | Active not recruiting 2, Completed 2 |
Follow Exablate BBBD: new trials by email Literature Review of Exablate BBBD trials Research Report on Exablate BBBD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Exablate, Doxorubicin - Brain Tumor | Phase 1 / Phase 2 | Active not recruiting | InSightec | 10 | 2023-01-04 | 2026-04-17 |
| Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG Exablate, Doxorubicin - Brain Tumor | Phase 1 / Phase 2 | Active not recruiting | InSightec | 10 | 2023-01-04 | 2026-04-21 |
| Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy Carboplatin, Exablate BBBD - Recurrent Glioblastoma | Phase 1 / Phase 2 | Completed | InSightec | 28 | 2020-11-06 | 2026-03-20 |
| Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM Exablate BBBD, Carboplatin - Recurrent Glioblastoma | Phase 1 / Phase 2 | Completed | InSightec | 13 | 2020-10-13 | 2026-01-20 |
Brain Neoplasms (2) · Glioblastoma (2)
InSightec (4)
Canada (2) · United States (2) · Italy (1) · South Korea (1)